BROOKSIDE GROUP PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: K81047 | READING, RG6 5HZ
Showing results 501-550 of 702
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Guanfacine | 25 | 686 | £1.3K | -2.7% ▼ |
| Opicapone | 25 | 1,500 | £3.0K | +30.6% ▲ |
| Erythromycin ethylsuccinate | 25 | 2,648 | £449 | +7.1% ▲ |
| Itraconazole | 25 | 1,011 | £453 | +86.4% ▲ |
| Tamsulosin and dutasteride hydrochloride | 25 | 616 | £181 | -28.5% ▼ |
| Powder 3.7 kcal/g energy and protein fortifier (0913081) | 25 | 1,526 | £3.5K | +300.9% ▲ |
| Timolol and travoprost | 25 | 130 | £440 | -22.6% ▼ |
| Betamethasone sodium phosphate | 25 | 270 | £62 | +275.3% ▲ |
| Lisinopril with diuretic | 24 | 1,288 | £458 | +17.0% ▲ |
| Analgesics with anti-emetics | 24 | 756 | £250 | +69.6% ▲ |
| Ivermectin | 24 | 191 | £2.3K | +146.0% ▲ |
| Glucagon | 24 | 25 | £412 | +57.8% ▲ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 24 | 2,060 | £99 | +59.7% ▲ |
| Timolol and brimonidine | 24 | 290 | £594 | +71.0% ▲ |
| Mupirocin | 24 | 123 | £165 | +104.4% ▲ |
| Menthol | 24 | 9,200 | £325 | -14.8% ▼ |
| Cimetidine | 23 | 2,136 | £195 | +23.3% ▲ |
| Ipratropium bromide | 23 | 25 | £132 | -20.0% ▼ |
| Galantamine | 23 | 1,260 | £1.4K | -39.2% ▼ |
| Metformin hydrochloride/sitagliptin | 23 | 1,820 | £311 | -38.6% ▼ |
| Empagliflozin/metformin | 23 | 2,576 | £1.6K | -55.8% ▼ |
| Febuxostat | 23 | 1,260 | £230 | -38.4% ▼ |
| Budesonide | 22 | 2,245 | £2.3K | +40.4% ▲ |
| Terazosin hydrochloride | 22 | 1,400 | £223 | +35.3% ▲ |
| Ready to serve 1 kcal/ml milkshake lower energy (0913021) | 22 | 182.0K | £3.4K | +119.3% ▲ |
| Fusidic acid | 22 | 205 | £698 | +113.0% ▲ |
| Lodoxamide trometamol | 22 | 230 | £114 | +260.6% ▲ |
| 22 | 2,500 | £265 | -1.6% vs avg | |
| 22 | 780 | £5.1K | +151.4% ▲ | |
| INR blood testing reagents | 21 | 528 | £1.5K | +178.7% ▲ |
| Desloratadine | 21 | 1,634 | £197 | -27.2% ▼ |
| Primidone | 21 | 1,484 | £2.0K | -41.0% ▼ |
| Rotigotine | 21 | 952 | £3.6K | -22.2% ▼ |
| Deflazacort | 21 | 1,598 | £402 | +138.0% ▲ |
| Oestrogens conjugated | 21 | 2,044 | £600 | +2.9% ▲ |
| Zinc oxide | 21 | 4,885 | £151 | +4.4% ▲ |
| 21 | 340 | £438 | +21.9% ▲ | |
| Cinacalcet hydrochloride | 20 | 1,008 | £276 | -13.8% ▼ |
| Ready to serve infant formula, high energy (0913104) | 20 | 297.6K | £3.6K | +81.0% ▲ |
| 20 | 260 | £475 | -39.1% ▼ | |
| 20 | 736 | £1.8K | -2.4% ▼ | |
| Alverine citrate | 19 | 2,260 | £88 | -54.1% ▼ |
| Alverine citrate/simeticone | 19 | 1,692 | £197 | +81.7% ▲ |
| Dronedarone hydrochloride | 19 | 1,576 | £1.7K | +31.5% ▲ |
| Olmesartan medoxomil | 19 | 1,036 | £46 | -72.4% ▼ |
| Naftidrofuryl oxalate | 19 | 2,352 | £271 | -41.7% ▼ |
| Doxylamine succinate/pyridoxine hydrochloride | 19 | 920 | £1.3K | +72.2% ▲ |
| Brivaracetam | 19 | 5,696 | £3.9K | -44.1% ▼ |
| Betamethasone sodium phosphate | 19 | 634 | £86 | +54.5% ▲ |
| Fesoterodine fumarate | 19 | 812 | £69 | -51.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.